Pioglitazone 30mg Tablets

Pioglitazone 30mg is an oral thiazolidinedione used to improve insulin sensitivity in adults with type 2 diabetes for pioglitazone treatment. It helps muscle and fat tissues respond better to insulin and lowers hepatic glucose output, so glucose control improves gradually rather than immediately. Use is limited to type 2 diabetes management. It should not be used for type 1 diabetes or diabetic ketoacidosis. Pioglitazone can be useful when insulin resistance is a major driver, but patient selection matters because it can cause fluid retention, edema, weight gain, and worsening or new heart failure. Seek review for breathlessness, rapid weight gain, ankle swelling, chest discomfort, jaundice, dark urine, vision changes, or repeated low-glucose episodes.
Take Pioglitazone 30mg exactly as prescribed, usually once daily with or without food. Continue diet, activity, glucose monitoring, and HbA1c review. Do not stop or combine diabetes medicines without medical advice.
Pioglitazone activates PPAR-gamma receptors, improving insulin sensitivity in peripheral tissues and reducing insulin resistance.
Possible effects include weight gain, swelling, headache, respiratory infection symptoms, and low blood sugar when combined with insulin or sulfonylureas. Serious concerns include heart failure, liver injury, macular edema, fractures, and severe allergy.
Review heart failure, edema, liver disease, bladder-cancer history, macular edema, fracture risk, pregnancy, breastfeeding, insulin, sulfonylureas, gemfibrozil, rifampicin, and glucose-monitoring plan.
Type 2 diabetes mellitus in adults when pioglitazone therapy is prescribed.
Improves insulin sensitivity and can support longer-term glucose control in selected adults with type 2 diabetes.
Pioglitazone 30mg is used to improve blood-sugar control in adults with type 2 diabetes for pioglitazone treatment.
Pioglitazone can cause fluid retention and may worsen or trigger heart failure in susceptible patients.
By itself the risk is lower, but hypoglycemia risk increases when used with insulin or sulfonylureas.
Glucose improvement is gradual and is usually assessed with home readings and HbA1c over weeks to months.
Breathlessness, rapid weight gain, ankle swelling, jaundice, dark urine, vision changes, or repeated low glucose need review.
Pioglitazone, Thiazolidinedione diabetes medicine, Insulin resistance treatment, Type 2 diabetes glucose control, Edema heart failure warning, HbA1c monitoring, AR: Pioglitazone أقراص, FR: Pioglitazone comprimé, PT: Pioglitazone comprimido, ES: Pioglitazone tableta, RU: Pioglitazone таблетки, ID: Pioglitazone, VI: Pioglitazone viên nén, MS: Pioglitazone, TL: Pioglitazone tableta, ZH-SG: Pioglitazone 片剂
International B2B Enquiry
Send a structured B2B enquiry for Pioglitazone 30mg Tablets under Diabetes Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Pioglitazone 30mg Tablets